Home/Filings/4/0001104659-12-056661
4//SEC Filing

ROUSSEAU FRANCK 4

Accession 0001104659-12-056661

CIK 0001274644other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 6:15 PM ET

Size

5.6 KB

Accession

0001104659-12-056661

Insider Transaction Report

Form 4
Period: 2012-08-07
ROUSSEAU FRANCK
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2012-08-07+8,0008,000 total
    Exercise: $4.24Exp: 2022-08-07Common Stock (8,000 underlying)
Footnotes (2)
  • [F1]Option to purchase Common Stock granted by the Issuer pursuant to the Issuer's 2011 Stock Option and Incentive Plan, qualified under Rule 16b-3(d).
  • [F2]This option may be exercised with respect to 25% of the shares underlying the option when the Reporting Person completes twelve (12) months of continuous service following August 7, 2012. In addition, this option may be exercised with respect to 6.25% of the shares underlying the option when the Reporting Person completes each calendar quarter of continuous service thereafter.

Documents

1 file

Issuer

TRANZYME INC

CIK 0001274644

Entity typeother

Related Parties

1
  • filerCIK 0001185955

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:15 PM ET
Size
5.6 KB